stockportfolio.pro
Alcon Inc. (ALC)
Healthcare · Medical Instruments & Supplies · NYSE
Alcon Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $8.72B | $9.46B | $9.91B | $10.40B |
| Gross profit | $4.75B | $5.25B | $5.51B | $5.75B |
| Net income | $335.00M | $974.00M | $1.02B | $980.00M |
| Net margin | 3.8% | 10.3% | 10.3% | 9.4% |
Source: Alcon Inc. SEC filings (10-K).
What growth is priced into ALC stock?
At today's market cap of $32.24B, Alcon Inc. is priced for free-cash-flow growth of about 7.7% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.61B from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Alcon Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ALC in your portfolio →
Alcon Inc. financial history by metric
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Alcon Inc. — frequently asked questions
What is Alcon Inc.'s revenue?
Alcon Inc. (ALC) reported revenue of $10.40B for fiscal year 2025, up 4.9% from the prior year, according to its SEC filings.
Is Alcon Inc. profitable?
Yes. ALC earned net income of $980.00M in fiscal 2025, a net margin of 9.4%.
What is ALC's P/E ratio?
Alcon Inc. trades at a price-to-earnings ratio of about 39.6 based on the latest data in our nightly-refreshed cache.
How fast is Alcon Inc. growing?
ALC's revenue grew at roughly 6.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Alcon Inc. have?
As of fiscal year 2025, ALC carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Alcon Inc.'s gross margin?
ALC's gross margin was 55.2% in fiscal 2025 — gross profit of $5.75B on revenue of $10.40B.
What is Alcon Inc.'s market cap?
Alcon Inc. (ALC) has a market capitalization of about $32.24B, based on the latest data in our nightly-refreshed cache.
When does Alcon Inc.'s fiscal year end?
ALC's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ALC stock?
At today's market cap of $32.24B, Alcon Inc. is priced for free-cash-flow growth of about 7.7% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.61B from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Alcon Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.